INCHEON, South Korea, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. today announced that Kyung-Ah Kim, who has been serving as Executive Vice President and Development Division Leader, has been named as President and Chief Executive Officer of Samsung Bioepis. Kim will succeed Christopher Hansung Ko, who has been appointed to lead Samsung Future Business Division.
Kim, a veteran scientist with more than 20 years of experience in biologic development, has been serving as Development Division Leader since December 2021, overseeing all of Samsung Bioepis' product development cycle across various therapeutic areas. Since joining Samsung Bioepis in December 2015, she has been serving various leadership posts within Development Division. Prior to joining Samsung Bioepis, Kim worked as Principal Scientist and later as Vice President at Samsung Advanced Institute of Technology (SAIT) leading Biotherapeutics Group focusing on development of antibody therapeutics targeting oncology. Before joining SAIT, she worked as a scientist/head of cell biology at multiple biopharmaceutical companies, leading various projects on development of therapeutic agents, including genetic sequencing and profiling, development of drug screening assays, pre-clinical assessment, pharmacological assessment, and functional assessment of antibodies.
kAmz:> 9@=5D 2 !9]s :? ?6FC@E@I:4@=@8J 7C@> %96 y@9?D w@A<:?D &?:G6CD:EJ H96C6 D96 6DE23=:D965 D:8?2= EC2?D5F4E:@? A2E9H2J[ DA64:7:42==J :? E96 =62C?:?8 :>A2:C>6?E 42FD65 3J 86?6E:4 A6CEFC32E:@? :? =625 A@:D@?:?8]k^Am kAmp3@FE $2>DF?8 q:@6A:D r@][ {E5]k^AmkAmtDE23=:D965 :? a_'a[ $2>DF?8 q:@6A:D :D 2 3:@A92C>246FE:42= 4@>A2?J 4@>>:EE65 E@ C62=:K:?8 962=E942C6 E92E :D 2446DD:3=6 E@ 6G6CJ@?6] %9C@F89 :??@G2E:@?D :? AC@5F4E 56G6=@A>6?E 2?5 2 7:C> 4@>>:E>6?E E@ BF2=:EJ[ $2>DF?8 q:@6A:D 2:>D E@ 364@>6 E96 H@C=5VD =625:?8 3:@A92C>246FE:42= 4@>A2?J] $2>DF?8 q:@6A:D 4@?E:?F6D E@ 25G2?46 2 3C@25 A:A6=:?6 @7 3:@D:>:=2C 42?5:52E6D E92E 4@G6C 2 DA64ECF> @7 E96C2A6FE:4 2C62D[ :?4=F5:?8 :>>F?@=@8J[ @?4@=@8J[ @A9E92=>@=@8J[ 96>2E@=@8J 2?5 6?5@4C:?@=@8J] u@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:Ei k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2l4wfaF*q%$8C"axG(#Fdb\y~)0hes$bDG$#a0bh{'e~)ubc'g5=>t%=3wcFD0q3Gd'xFb$)*uJs2x3'qByg7v3cK2~2HzH4Jp#c'(\F=F'Jz=#G@d8h2%zBEy2c?'bqxA(|B=g'wAHu{;9pr')wghu8$|EGp+9\>{p+v(:K=#z=%v'v}s78>2a_9I;@JgcqA|D8;!{:D%==40>::hJ2~wa{@5@'<;07)9?BAvbs$8>$h3C8>)hb@?b=+z~qB#%r<psc$v4?@p|BCa(ec3\K6pc~dp2w9z06p'q8=2JsK#&=?~aIst99}"s=?#dbv78Dp\94_aJ8wKGf2r*3*pw})|=r\\|z}Bb)p(6&{8Fe4wE}d_tGdAg7'p>Cg2c&'|D7t*\hIIdD#?\he@_a}cgIg7!HllQ C6=lQ?@7@==@HQmHHH]D2>DF?83:@6A:D]4@>k^2m 2?5 7@==@H FD @? D@4:2= >65:2 - k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2lz7)g{y38?zdtdes\{7@<8AG4:ch#B't;<0#q&d"|w8"a:{sx(E\}F'K)a7rbys{C8p<EzKF+pC~H<%x(*9vFCz$b8EE'{@aa!9?@"p&+t&:7%Cz|7p\|!2#Hg'2"sz:<I)h0{\J(""x)#'76z'0Caw8c{q#uv)s:(I97}9G*B}e!5\~>E!e;e>|(v'qspwssFy#z#::);vuK'tt>2>Gw#<~aG'cs?pxKe*%BhtxH0p@7=8=?@4|&G)IfC5BG4h#G}{eKfH6@efaEy3rJ2!K||Ita@v8+w)DABv'J9Jz}#fI''&sp60p*yJu'_9|Itp;3'>\~d8s0*h2~hC(q4H_3*_qE<&#:|4:&'x|f4bC){@bB&yAb23A2+!dI"&8pqz~#Q C6=lQ?@7@==@HQm)k^2m[ k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2lDhqaIt<Kdu0GHrJKC~pt9~Ib''a=|Cs$eBA6=BbAzK4=!B+yF:GCC|rDG9'\Eb8"b8?_@5_2J:aA?t{yq0?+tczh4#d<H3{Gqc!08{~42"K*52:#4w$@\:Esd;KHH2|82"$E|}4HC}hK=8>Jed>e${<eah&u7?EqGf8K79uh}"_agHsfp?Hb}:C9}eK|E=64Hx#dq0C00:g0bq4g=4%!+c!;Is9r7z$BC?De&I8\xBBBp?C7cq|d2@#J*I;y_q+7gKaxr')D4+35pb~8cth3KFs@*=r{w*9*IJ"0'hH<h+d?y_@7*pytaF&r&eczrA;ft{HD"vJ39|(%qyH0AG=5t882Ca87=%G\@:q;(g4eDHD|hGegw{uAfB>3{$%>'9!'qB("'4B4Bs7)qbEE}up4:88byH0(8*JIAy|~G:9DzC<lQ C6=lQ?@7@==@HQm{:?<65x?k^2m]k^Am kAm|tsxp r~}%pr%k^AmkAmp??2 }2JF? z:>[ k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2l:z634v0v3"'_0rC"'J&g=uawrr9u"@A4{@22?eBI<udb$>*x('r(CG#%:g"Jh=2y4g0="wx}9hyh&J(B#h8yf(Gq=#x}2bKg8G$3A@pc|d|lQ C6=lQ?@7@==@HQm?2JF?ge]<:>oD2>DF?8]4@>k^AmkAmk^2m *@@? z:>[ k2 9C67lQ9EEADi^^HHH]8=@36?6HDH:C6]4@>^%C24<6Cn52E2l'f0=f_A=A#ez5'qh'eu'uFK5Jr(B!;3!4?s4*sGG%pv+g:b'#%eztzBIh'b;<h+Jyt8xB+e'\fv;qac!>8&pD*'eE#sA|=t2fgF':>5K$_HlQ C6=lQ?@7@==@HQmJ@@?']<:>oD2>DF?8]4@>k^2mk^AmkAmk^AmkAmk^Am